AGMB (AgomAb Therapeutics NV) OCF Yield %: -9.41 (As of Jul. 12, 2026)


AGMB AgomAb Therapeutics NV AGMB
14 GF Score
Price $13.08
! 1 Warning Sign
View Full Analysis

What is AgomAb Therapeutics NV OCF Yield %?

AgomAb Therapeutics NV AGMB +0.85% 14 OCF Yield % is -9.41 as of Jul. 12, 2026. GuruFocus rates AGMB with a GF Score™ of 14/100. The stock has 1 warning sign investors should review. Among 1,410 Biotechnology companies, AgomAb Therapeutics NV ranks worse than 52.91% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, AgomAb Therapeutics NV's Trailing 12-Month Cash Flow from Operations is $0.00 Mil, and Market Cap is $644.19 Mil. Therefore, AgomAb Therapeutics NV's OCF Yield % for today is -9.41%.

The historical rank and industry rank for AgomAb Therapeutics NV's OCF Yield % or its related term are showing as below:

AGMB' s OCF Yield % Range Over the Past 10 Years
Min: -9.41   Med: 0   Max: -9.41
Current: -9.41

During the past 5 years, the highest OCF Yield % of AgomAb Therapeutics NV was -9.41%. The lowest was -9.41%. And the median was %.

AGMB's OCF Yield % is ranked worse than
52.91% of 1410 companies
in the Biotechnology industry
Industry Median: -8.26 vs AGMB: -9.41

AgomAb Therapeutics NV's OCF Margin % for the quarter that ended in Dec. 2025 was %.

AgomAb Therapeutics NV OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

AgomAb Therapeutics NV OCF Yield % Related Terms

AgomAb Therapeutics NV OCF Yield % Historical Data

* Premium members only.

The historical data trend for AgomAb Therapeutics NV's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AgomAb Therapeutics NV OCF Yield % Chart

AgomAb Therapeutics NV Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
0.00 0.00 0.00 0.00 0.00

AgomAb Therapeutics NV Quarterly Data
Dec21 Dec22 Dec23 Dec24 Sep25 Dec25
OCF Yield % Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

AGMB vs DNA, ACRS, RLMD: OCF Yield % Comparison

For the Biotechnology subindustry, AgomAb Therapeutics NV's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AgomAb Therapeutics NV OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AgomAb Therapeutics NV's OCF Yield % distribution charts can be found below:

* The bar in red indicates where AgomAb Therapeutics NV's OCF Yield % falls into.


AGMB
14GF Score
AgomAb Therapeutics NV AGMB
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AgomAb Therapeutics NV OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

AgomAb Therapeutics NV's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-60.587 / 0
=N/A%

AgomAb Therapeutics NV's annualized OCF Yield % for the quarter that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=0 * 4 / 0
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -9.41 mean?
AgomAb Therapeutics NV (AGMB) has a OCF Yield % of -9.41 as of Jul. 12, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on AgomAb Therapeutics NV and its competitors. According to the industry distribution chart, AgomAb Therapeutics NV ranks #746 out of 1410 companies in the Biotechnology industry, placing it in the top 52.9%.
Is AgomAb Therapeutics NV's OCF Yield % too high?
AgomAb Therapeutics NV's current OCF Yield % is -9.41. Based on the distribution chart, AgomAb Therapeutics NV ranks #746 out of 1410 companies in the Biotechnology industry, which is below the industry midpoint. Overall, AgomAb Therapeutics NV has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does AgomAb Therapeutics NV's OCF Yield % compare to DNA and ACRS?
According to the Biotechnology industry distribution chart, AgomAb Therapeutics NV ranks #746 out of 1410 companies for OCF Yield %. This places AgomAb Therapeutics NV in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on AgomAb Therapeutics NV and its competitors. AgomAb Therapeutics NV's current OCF Yield % is -9.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AgomAb Therapeutics NV stock overvalued right now?
AgomAb Therapeutics NV (AGMB) has a current OCF Yield % of -9.41. The current OCF Yield % is -9.41. AgomAb Therapeutics NV's overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For AgomAb Therapeutics NV (AGMB), the current OCF Yield % is -9.41 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AgomAb Therapeutics NV Business Description

Address 1/6 Posthoflei, Antwerp, BEL, 2600
AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.
14GF Score

Get the complete analysis for AGMB

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.08
Price